Securities Code: 301235
Convertible Bond Code: 123251
Securities Abbreviation: Huakang Clean
Convertible Bond Abbreviation: Huayi Convertible Bond
Wuhan Huakang Century Clean Technology Co., Ltd.
Issuance of Convertible Corporate Bonds to Undefined Targets
2026 First Interim Trustee Management Report
Bond Trustee Manager:
GUOLIAN MINSHENG INVESTMENT BANKING COMPANY LIMITED
(No. 8, Puming Road, China (Shanghai) Pilot Free Trade Zone)
July 2026
Important Statement
This report is prepared by Guolian Minsheng Securities Underwriting and Sponsorship Co., Ltd. (hereinafter referred to as "Guolian Minsheng Underwriting" or "Trustee Manager") in accordance with the "Administrative Measures for the Issuance and Trading of Corporate Bonds," "Guidelines for the Professional Conduct of Bond Trustee Managers," and the "Trustee Management Agreement" for the issuance of convertible corporate bonds to undefined targets by Wuhan Huakang Century Medical Co., Ltd. (hereinafter referred to as the "Trustee Management Agreement"). It is noted that "Wuhan Huakang Century Medical Co., Ltd." has been renamed "Wuhan Huakang Century Clean Technology Co., Ltd.," and "Huaying Securities Co., Ltd." has been renamed "Guolian Minsheng Securities Underwriting and Sponsorship Co., Ltd." This report is also based on relevant regulations, public information disclosure documents, announcements issued by Wuhan Huakang Century Clean Technology Co., Ltd. (hereinafter referred to as "Huakang Clean," "the Company," or "the Issuer"), and other provided materials.
This report only explains matters related to the trustee management of the company's bonds and does not constitute any investment advice regarding the company's bonds. Investors should make independent judgments on relevant matters and should not rely on any content in this report as a commitment or statement made by Guolian Minsheng Underwriting. In any event, Guolian Minsheng Underwriting shall not bear any responsibility for any action or inaction taken by investors based on this report.
Guolian Minsheng Underwriting serves as the trustee manager for Huakang Clean's issuance of convertible corporate bonds to undefined targets (bond abbreviation "Huayi Convertible Bond," bond code 123251) and continuously monitors matters that have a significant impact on the rights and interests of bondholders. In accordance with relevant regulations, including the "Administrative Measures for the Issuance and Trading of Corporate Bonds," "Guidelines for the Professional Conduct of Bond Trustee Managers," and the "Administrative Measures for Convertible Corporate Bonds," as well as the provisions of the "Trustee Management Agreement" for this bond and the "Announcement on Early Redemption of 'Huayi Convertible Bond'" disclosed by the issuer on July 7, 2026, the following is a report on major matters concerning this bond:
I. Approval Documents and Scale
The plan and related matters for Huakang Clean's issuance of convertible corporate bonds to undefined targets were deliberated and approved by the Fifth Meeting of the Second Board of Directors on April 21, 2023, the Eighth Meeting of the Second Board of Directors on August 16, 2023, the Eleventh Meeting of the Second Board of Directors on December 22, 2023, and the Fourteenth Meeting of the Second Board of Directors on April 28, 2024. They were also approved by the 2022 Annual General Meeting of Shareholders on May 16, 2023, and the Second Extraordinary General Meeting of Shareholders in 2024 on May 15, 2024.
With the approval of the China Securities Regulatory Commission's "Approval on the Registration of Wuhan Huakang Century Medical Co., Ltd. for Issuing Convertible Corporate Bonds to Undefined Targets" (Document No. [2024]220), the Company issued 7.5 million convertible corporate bonds on December 23, 2024, with a face value of 100 RMB per bond. The total amount raised was 750,000,000.00 RMB. After deducting underwriting and sponsorship fees, accounting fees, legal fees, credit rating fees, and other issuance expenses (excluding VAT), totaling 6,183,142.52 RMB, the net proceeds from the issuance were 743,816,857.48 RMB. These funds were received on December 27, 2024, and the receipt of these funds was audited by HZ Zhonghui Certified Public Accountants (Special General Partnership), who issued the "Audit Report" (Document No. Zhonghui Hui Yan [2024]11046) on December 27, 2024.